Carzo, Analyn R.

HRN: 16-28-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/03/2024
02/10/2024
IV
500mg
Q8
Exla AP
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: